$Pfizer (PFE.US)$ Pfizer announced its financial performance for the third quarter of 2024 and raised its forecast for full-year revenue and adjusted diluted earnings per share for 2024. Pfizer has raised its full-year revenue forecast to $61-64 billion and raised its adjusted diluted earnings per share forecast to $2.75-2.95. Pfizer's revenue for the third quarter was $17.7 billion, a 32% year-on-year increase; earnings per share were $0.78.